YTHDF1 promotes cancer stem cell renewal and resistance to tyrosine kinase inhibitors in hepatocellular carcinoma (HCC), which enhances the stability and translation of m6A-modified NOTCH1 mRNA, leading to increased expression of NOTCH1 target genes. This evidence concerns the gene NOTCH1 and cancer.